174 related articles for article (PubMed ID: 37643526)
21. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
22. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
23. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA HOTAIRM1 inhibits cell progression by regulating miR-17-5p/ PTEN axis in gastric cancer.
Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Zhang Z; Hu H
J Cell Biochem; 2019 Apr; 120(4):4952-4965. PubMed ID: 30302796
[TBL] [Abstract][Full Text] [Related]
25. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
26. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression.
Siddique R; Thangavelu L; S R; Almalki WH; Kazmi I; Kumar A; Mahajan S; Kalra H; Alzarea SI; Pant K
Pathol Res Pract; 2024 Jun; 258():155333. PubMed ID: 38723325
[TBL] [Abstract][Full Text] [Related]
27. PI3K/PTEN signaling in tumorigenesis and angiogenesis.
Jiang BH; Liu LZ
Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
29. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
Yan Y; Huang H
Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
[TBL] [Abstract][Full Text] [Related]
30. lncRNA GAS5 restrains CCl
Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
[TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
[TBL] [Abstract][Full Text] [Related]
32. The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.
Zhu L; Li Z; Yu X; Ruan Y; Shen Y; Shao Y; Zhang X; Ye G; Guo J
Stem Cell Res Ther; 2021 Jul; 12(1):418. PubMed ID: 34294122
[TBL] [Abstract][Full Text] [Related]
33. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM
Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665
[TBL] [Abstract][Full Text] [Related]
34. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
[TBL] [Abstract][Full Text] [Related]
35. Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.
Lee KT; Gopalan V; Lam AK
Histol Histopathol; 2019 Jun; 34(6):593-609. PubMed ID: 30620381
[TBL] [Abstract][Full Text] [Related]
36. Epigenetically silenced LINC02381 functions as a tumor suppressor by regulating PI3K-Akt signaling pathway.
Jafarzadeh M; Soltani BM; Soleimani M; Hosseinkhani S
Biochimie; 2020; 171-172():63-71. PubMed ID: 32092325
[TBL] [Abstract][Full Text] [Related]
37. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
39. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
[TBL] [Abstract][Full Text] [Related]
40. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]